The program objectives are to train head and neck surgical oncologists in 1) multi-disciplinary head and neck oncology clinical practice;2) basic science, translational, health-services and/or clinical research, methodology;and 3) didactic and clinical educational skills, so that they can provide leadership in academic departments of head and neck surgery. With a striking decrease in the number of applicants to head and neck surgical oncology training programs nationally, established and funded programs, which provide research and clinical training, are needed to maintain the high standards of academic training to address an impending health care shortfall of qualified head and neck surgical oncologists. To achieve these objectives, we continue to offer a three-year fellowship curriculum that includes 24 months of laboratory, translational, health-services and/or clinical research training, and 12 months of advanced head and neck surgical oncology training in which the trainees have extensive exposure to medical oncology, radiation oncology, speech pathology, and dental oncology. A mandatory core curriculum provided through the Institution's Graduate Medical Education Program provides training in the theory and practice of radiation and medical oncology, cancer biology, research ethics, responsible conduct of research, clinical trial design, and biostatistics. The Department of Head and Neck Surgery has its own core curriculum and seminar series, which expands on these topics and applies them to those diseases of greatest relevance to head and neck oncologists. Instruction is also provided in research regulatory compliance with training in Human Subjects Research, HIPAA Compliance, Radiation and Biosafety, and Animal Care and Use. The program also includes optional academic course work through the Graduate Schools of Biomedical Sciences or Public Health that can culminate in a Master's Degree. One graduate of this program is currently completing additional training and three others hold faculty positions in our department and Baylor College of Medicine Department of Otolaryngology-Head and Neck Surgery. The current application seeks continued stipend support for trainees undergoing laboratory or Health services research training while the institution provides salary support for the period of advanced surgical training. Finally, we will continue the practice of recruiting, interviewing and enrolling trainees of both genders, and diverse cultural, racial and ethnic backgrounds.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA060374-15
Application #
7864180
Study Section
Subcommittee G - Education (NCI)
Program Officer
Lim, Susan E
Project Start
1995-08-01
Project End
2011-06-30
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
15
Fiscal Year
2010
Total Cost
$104,688
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Surgery
Type
Other Domestic Higher Education
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Osman, Abdullah A; Monroe, Marcus M; Ortega Alves, Marcus V et al. (2015) Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescence. Mol Cancer Ther 14:608-19
Neskey, David M; Osman, Abdullah A; Ow, Thomas J et al. (2015) Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer. Cancer Res 75:1527-36
Osman, Abdullah A; Neskey, David M; Katsonis, Panagiotis et al. (2015) Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients. Cancer Res 75:1205-15
Hah, J Hun; Zhao, Mei; Pickering, Curtis R et al. (2014) HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells. Head Neck 36:1547-54
Sandulache, Vlad C; Ow, Thomas J; Daram, Shiva P et al. (2013) Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival. Head Neck 35:1454-60
Sano, Daisuke; Gule, Maria K; Rosenthal, David I et al. (2013) Early postoperative epidermal growth factor receptor inhibition: safety and effectiveness in inhibiting microscopic residual of oral squamous cell carcinoma in vivo. Head Neck 35:321-8
Hamilton, J D; Ahmed, S; Sandulache, V C et al. (2013) Improving imaging diagnosis of persistent nodal metastases after definitive therapy for oropharyngeal carcinoma: specific signs for CT and best performance of combined criteria. AJNR Am J Neuroradiol 34:1637-42
Sandulache, Vlad C; Skinner, Heath D; Wang, Yuan et al. (2012) Glycolytic inhibition alters anaplastic thyroid carcinoma tumor metabolism and improves response to conventional chemotherapy and radiation. Mol Cancer Ther 11:1373-80
Sandulache, Vlad C; Skinner, Heath D; Ow, Thomas J et al. (2012) Individualizing antimetabolic treatment strategies for head and neck squamous cell carcinoma based on TP53 mutational status. Cancer 118:711-21
Sandulache, Vlad C; Myers, Jeffrey N (2012) Altered metabolism in head and neck squamous cell carcinoma: an opportunity for identification of novel biomarkers and drug targets. Head Neck 34:282-90

Showing the most recent 10 out of 49 publications